We look deeper into the biology of
growth factors and disease to discover
new treatments for patients
Scholar Rock® is discovering and developing a pipeline of innovative new medicines to treat a range of serious diseases with high unmet medical need. Learn More
For Clinicians & Patients:
We are working to advance SRK-015, our lead drug program, into clinical trials for the improvement of muscle function in Spinal Muscle Atrophy, a rare genetic disease. Learn More
Our Technology
Supracellular Activation is a proprietary approach for highly selective targeting of growth factors.
Our Technology
Supracellular Activation is a proprietary approach for highly selective targeting of growth factors.
